drugset / Trial / NCT04041167

Impact of Lipoic Acid Use on Stroke Outcome After Reperfusion Therapy in Patients With Diabetes (IMPORTANT)

NCT04041167

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to investigate the effectiveness and safety of alpha-lipoic acid in patients with diabetes and ischemic stroke treated with reperfusion therapy.

Timeline

Start
2018-08-01
Primary completion
2021-07-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 600 mg Intravenous

Indications